Landon Donovan recently had a hair transplant, leading to noticeable changes in his appearance. The conversation revolves around his confidence and reactions to his new look.
Microneedling promotes hair growth by increasing circulation and collagen production, with gains potentially lasting longer than those from minoxidil. Some users report sustained results after stopping microneedling, unlike with minoxidil and finasteride.
Using a topical formula with 5% minoxidil and 0.01% retinoic acid is considered effective, as tretinoin can enhance minoxidil results and improve scalp health.
The user reported significant hair recovery using topical minoxidil combined with the Age-R Booster-H-device, alongside oral finasteride and weekly dermaroller use. The device improved minoxidil absorption, leading to visible new hair growth.
A 32-year-old had a hair transplant in Istanbul for 2500€, using 2800-3000 grafts, and is not using finasteride or other medications long-term. The user is satisfied with the results but acknowledges the possibility of needing another transplant in the future.
A user shared their 4-month hair restoration progress using minoxidil with finasteride, oral finasteride, and micro needling. The community responded positively, praising the results and the user's happy demeanor in photos.
A user's results after 10 months of hair transplant surgery, which they had been taking care of with 0.5mg/day finasteride, 1x daily minoxidil and 1.5 times weekly microneedling treatments. One other user replied positively to the post.
PP405 is a new hair loss treatment showing early promise with a 20% hair density increase, but skepticism exists due to past failures of similar treatments like Pyrilutamide, RU58841, and Bimatoprost. Users debate its potential effectiveness, with some hopeful due to Google's involvement, while others urge caution without more evidence.
The conversation discusses hair regrowth progress after 2.5 months using pyrilutamide and minoxidil. Participants note visible improvement in a short time.